DEXELANCE S.P.A. financials
DEXELANCE S.P.A.
8156009C6B018FE67A34 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | €329.3M | €292.3M |
| Other income | €4.9M | €5.0M |
| Employee benefits expense | €53.5M | €44.1M |
| Raw materials & consumables used | €126.8M | €112.3M |
| Depreciation & amortisation | €22.5M | €17.0M |
| Operating profit (EBIT) | €27.4M | €35.1M |
| Finance costs | €15.6M | €14.1M |
| Profit before tax | €25.6M | €37.3M |
| Income tax expense | €7.7M | €9.2M |
| Profit for the year | €17.9M | €28.1M |
| — attributable to owners | €17.9M | €28.0M |
| — attributable to NCI | €0 | €123.0K |
| Total comprehensive income | €17.8M | €26.9M |
| Per share | ||
| Basic EPS | €0.67 | €1.15 |
| Diluted EPS | €0.67 | €1.15 |
| Cash flow statement | ||
| Net cash from operating activities | €39.2M | €19.8M |
| Income taxes paid | -€6.9M | -€12.5M |
| Net cash from investing activities | -€21.4M | -€110.2M |
| Net cash from financing activities | -€25.5M | €88.9M |
| Dividends paid | — | €700.0K |
| Proceeds from borrowings | €14.2M | €52.4M |
| Repayments of borrowings | €29.3M | €23.3M |
| Lease liability payments | €8.2M | €5.4M |
| Balance sheet | ||
| Total assets | €471.1M | €475.5M |
| Non-current assets | €306.8M | €313.7M |
| Property, plant & equipment | €28.2M | €28.6M |
| Right-of-use assets | €34.4M | €32.9M |
| Intangible assets & goodwill | €235.5M | €243.6M |
| Current assets | €164.3M | €161.7M |
| Inventories | €37.1M | €36.9M |
| Trade & other receivables | €41.6M | €39.0M |
| Cash & equivalents | €33.7M | €41.5M |
| Total equity | €170.5M | €154.4M |
| — attributable to owners | €170.5M | €154.4M |
| Non-controlling interests | €0 | €0 |
| Long-term borrowings | €39.5M | €63.9M |
| Lease liabilities (non-current) | €29.4M | €28.0M |
| Current liabilities | €141.5M | €125.2M |
| Short-term borrowings | €23.6M | €20.4M |
| Lease liabilities (current) | €6.5M | €5.7M |
| Deferred tax liabilities | €23.9M | €25.7M |
| Derived metrics | ||
| Operating margin | 8.3% | 12.0% |
| Net margin | 5.4% | 9.6% |
| Return on equity | 10.5% | 18.2% |
| Cash conversion ratio | 2.19× | 0.70× |
| Other reported items | ||
| Adjustments For Amortisation Expense | €22.5M | €17.0M |
| Adjustments For Decrease Increase In Contract Assets | €3.7M | €1.4M |
| Adjustments For Decrease Increase In Inventories | €229.0K | €2.7M |
| Adjustments For Decrease Increase In Trade Account Receivable | €2.6M | €6.9M |
| Adjustments For Impairment Loss Recognised In Profit Or Loss Goodwill | €43.0K | -€206.0K |
| Adjustments For Income Tax Expense | -€7.7M | -€9.2M |
| Adjustments For Increase Decrease In Contract Liabilities | -€2.1M | €3.2M |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | €846.0K | €748.0K |
| Adjustments For Increase Decrease In Trade Account Payable | -€2.3M | €1.7M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | €174.0K | -€54.0K |
| Adjustments For Provisions | €877.0K | €459.0K |
| Brand Names | €57.5M | €57.5M |
| Cash Flows From Used In Increase Decrease In Current Borrowings | -€284.0K | -€1.8M |
| Cash Flows From Used In Operations Before Changes In Working Capital | €51.5M | €53.1M |
| Cash Payments For Future Contracts Forward Contracts Option Contracts and Swap Contracts Classified As Investing Activities | €9.2M | €38.1M |
| Changes In Inventories of Finished Goods and Work In Progress | -€392.0K | -€2.5M |
| Comprehensive Income Attributable To Noncontrolling Interests | €0 | €123.0K |
| Comprehensive Income Attributable To Owners of Parent | €17.8M | €26.8M |
| Consideration Paid Received | €0 | €42.4M |
| Current Contract Assets | €8.4M | €4.8M |
| Current Contract Liabilities For Performance Obligations Satisfied Over Time | €16.6M | €14.4M |
| Current Provisions For Employee Benefits | €10.6M | €10.1M |
| Current Tax Assets | €1.4M | €4.1M |
| Current Tax Assets Noncurrent | €4.1M | €3.6M |
| Current Tax Liabilities | €1.0M | €1.3M |
| Dividends Paid To Equity Holders of Parent Classified As Financing Activities | €0 | €700.0K |
| Equity and Liabilities | €471.1M | €475.5M |
| Finance Income | €13.8M | €16.3M |
| Gains Losses On Cash Flow Hedges Before Tax | -€54.0K | -€913.0K |
| Gains Losses On Cash Flow Hedges Net of Tax | -€41.0K | -€694.0K |
| Gains Losses On Exchange Differences On Translation Net of Tax | €12.0K | -€186.0K |
| Income Tax Relating To Cash Flow Hedges of Other Comprehensive Income | -€13.0K | -€219.0K |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | -€21.0K | -€76.0K |
| Increase Decrease In Cash and Cash Equivalents | -€7.8M | -€1.5M |
| Increase Decrease Through Acquisition of Subsidiary | — | -€662.0K |
| Increase Decrease Through Appropriation of Retained Earnings | €0 | €0 |
| Increase Decrease Through Sharebased Payment Transactions | €183.0K | — |
| Investments In Associates Accounted For Using Equity Method | €6.0K | €6.0K |
| Issue of Equity | — | €70.1M |
| Issued Capital | €26.9M | €26.9M |
| Liabilities | €300.7M | €321.1M |
| Miscellaneous Other Operating Expense | €2.3M | €1.2M |
| Noncurrent Financial Liabilities | €159.2M | €195.9M |
| Noncurrent Portion of Other Noncurrent Borrowings | €4.9M | €114.0K |
| Noncurrent Provisions For Employee Benefits | €7.4M | €7.0M |
| Other Adjustments For Noncash Items | -€174.0K | -€192.0K |
| Other Adjustments To Reconcile Profit Loss | €8.5M | €13.2M |
| Other Comprehensive Income | €132.0K | €1.2M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | -€88.0K | -€319.0K |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | -€67.0K | -€242.0K |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | -€65.0K | -€997.0K |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | -€67.0K | -€242.0K |
| Other Current Assets | €7.4M | €6.9M |
| Other Current Borrowings and Current Portion of Other Noncurrent Borrowings | €0 | €0 |
| Other Current Financial Assets | €34.6M | €28.6M |
| Other Current Financial Liabilities | €14.5M | €7.6M |
| Other Current Liabilities | €42.2M | €39.0M |
| Other Current Nonfinancial Liabilities | €15.0M | €14.5M |
| Other Intangible Assets | €1.9M | €1.6M |
| Other Longterm Provisions | €4.8M | €4.9M |
| Other Noncurrent Assets | €4.6M | €4.9M |
| Other Noncurrent Financial Liabilities | €47.4M | €65.4M |
| Other Noncurrent Liabilities | €1.9M | €839.0K |
| Proceeds From Issue of Ordinary Shares | €0 | €70.1M |
| Purchase of Financial Instruments Classified As Investing Activities | -€231.0K | €0 |
| Purchase of Treasury Shares | -€1.9M | -€47.0K |
| Recipes Formulae Models Designs and Prototypes | €6.1M | €7.4M |
| Revenue From Contracts With Customers | €324.4M | €287.4M |
| Trade and Other Current Payables To Trade Suppliers | €53.6M | €51.3M |
Every line item above is a fact tagged in DEXELANCE S.P.A.'s annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.